BRUKER CORPORATION

NASDAQ: BRKR (Bruker Corporation)

最近更新时间: 17 May, 10:09AM

37.53

0.84 (2.29%)

  • 1天 2.29%
  • 5天 -1.73%
  • 1月 -7.86%
  • 6月 -36.92%
  • 今年至今天 -36.18%
  • 1年 -41.06%
  • 5年 -12.29%
前收盘价格 36.69
收盘价格 36.85
成交量 1,636,305
平均成交量 (3个月) 2,443,261
市值 5,686,995,968
市盈率 (P/E TTM) 72.17
预期市盈率 (P/E Forward) 16.18
价格/销量 (P/S) 1.62
股市价格/股市净资产 (P/B) 3.08
52周波幅
34.10 (-9%) — 78.94 (110%)
利润日期 4 Aug 2025 - 8 Aug 2025
股息率 (DY TTM) 0.53%
营业毛利率 2.31%
营业利益率 (TTM) 8.62%
稀释每股收益 (EPS TTM) 0.520
季度收入增长率 (YOY) 11.00%
季度盈利增长率 (YOY) -65.80%
总债务/股东权益 (D/E MRQ) 115.22%
流动比率 (MRQ) 1.57
营业现金流 (OCF TTM) 294.50 M
杠杆自由现金流 (LFCF TTM) 336.59 M
资产报酬率 (ROA TTM) 4.79%
股东权益报酬率 (ROE TTM) 4.76%

市场趋势

短期 中期
行业 Medical Devices (US) 看跌 混合的
Medical Devices (全球的) 看跌 混合的
股票 Bruker Corporation 看跌 看跌

AIStockmoo 评分

0.5
分析师共识 1.0
内部交易活动 1.5
价格波动 1.5
技术平均移动指标 -1.0
技术振荡指标 -0.5
平均 0.50

相关股票

股票 市值 DY P/E（TTM） P/B
BRKR 6 B 0.53% 72.17 3.08
MASI 8 B - - 8.43
LIVN 2 B - - 2.29
NVCR 2 B - - 5.53
ATEC 1 B - - 50.98
TNDM 1 B - - 8.85

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
部门 Healthcare
行业 Medical Devices
投资方式 Small Core
内部持股比例 31.97%
机构持股比例 82.09%

所有权

姓名 日期 持有股份
Pallas Capital Advisors Llc 31 Mar 2025 9,495,686
52周波幅
34.10 (-9%) — 78.94 (110%)
目标价格波幅
40.00 (6%) — 60.00 (59%)
高 60.00 (Wells Fargo, 59.87%) 购买
中 45.50 (21.24%)
低 40.00 (Citigroup, 6.58%) 保留
平均值 47.33 (26.11%)
总计 2 购买, 4 保留
平均价格@调整类型 39.11
公司 日期 目标价格 调整类型 价格@调整类型
Citigroup 22 May 2025 40.00 (6.58%) 保留 36.34
07 Apr 2025 50.00 (33.23%) 购买 38.70
Barclays 08 May 2025 46.00 (22.57%) 购买 40.51
10 Apr 2025 50.00 (33.23%) 购买 38.07
Goldman Sachs 08 May 2025 45.00 (19.90%) 保留 40.51
Stifel 08 May 2025 48.00 (27.90%) 保留 40.51
UBS 08 May 2025 45.00 (19.90%) 保留 40.51
Wells Fargo 17 Apr 2025 60.00 (59.87%) 购买 36.28

该时间范围内无数据。

  • 3M
日期 类型 细节
03 Jun 2025 公告 Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics
03 Jun 2025 公告 Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection
02 Jun 2025 公告 Bruker Launches New timsUltra AIP System with Further Enhanced, Extreme Sensitivity for Single-Cell Proteomics, FNA Biopsy Immunopeptidomics and Metaproteomics
02 Jun 2025 公告 Bruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity
30 May 2025 公告 Bruker Launches Revolutionary timsOmniTM Mass Spectrometer
30 May 2025 公告 Bruker Launches Novel timsMetabo™ Mass Spectrometer for Breakthrough 4D-Metabolomics and 4D-Lipidomics Sensitivity, Specificity and Annotation Confidence - at Speed, Depth, and Scale
30 May 2025 公告 Bruker Corporation to Present at the Jefferies Global Healthcare Conference
28 May 2025 公告 Bruker Introduces Novel MOVE-T System for Transferable, Robust Milk and Liquid Dairy Analysis with FT-NIR Technology
15 May 2025 公告 Bruker Announces Quarterly Dividend
14 May 2025 公告 Bruker and 10x Genomics Reach Global Settlement of Patent Litigation
07 May 2025 公告 Bruker Reports First Quarter 2025 Financial Results
25 Apr 2025 公告 Bruker Spatial Biology Pushes Boundaries in Spatial Biology and Multiomics at AACR 2025
24 Apr 2025 公告 Bruker to Launch Beacon Discovery™ at AACR 2025, Expanding Access to Live Single-Cell Functional Analysis
17 Apr 2025 公告 Bruker Introduces nVista 2P Miniature Microscope
16 Apr 2025 公告 Bruker Announces Majority Acquisition of RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring
11 Apr 2025 公告 Bruker Announces First Quarter 2025 Preliminary Revenue
11 Apr 2025 公告 Bruker Complements Fast, Cost-effective IR Biotyper® Hospital Hygiene Testing and HAI Tracing with NGS Reflex Testing
07 Apr 2025 公告 Bruker Announces First-of-a-kind 1.3 GHz High-Resolution NMR System
07 Apr 2025 公告 Bruker Introduces Innovative Fourier 80 Multinuclear Benchtop FT-NMR
02 Apr 2025 公告 Bruker Announces Introduction of Revolutionary d-DNP Polarizer for MRI Research and for Dynamic Nuclear Polarization Liquids NMR
显示更多
股息率 (DY TTM) 0.53%
5年平均股息收益率 0.28%
股息支付比率 38.46%
预计下次股息支付 Sep 2025
除息日 公告日期 支付日期 详情
17 Mar 2025 18 Feb 2025 28 Mar 2025 0.05 现金
02 Dec 2024 14 Nov 2024 16 Dec 2024 0.05 现金
30 Aug 2024 08 Aug 2024 16 Sep 2024 0.05 现金
03 Jun 2024 14 May 2024 17 Jun 2024 0.05 现金
29 Feb 2024 15 Feb 2024 15 Mar 2024 0.05 现金
30 Nov 2023 17 Nov 2023 15 Dec 2023 0.05 现金
31 Aug 2023 09 Aug 2023 15 Sep 2023 0.05 现金
31 May 2023 11 May 2023 16 Jun 2023 0.05 现金
28 Feb 2023 16 Feb 2023 17 Mar 2023 0.05 现金
30 Nov 2022 10 Nov 2022 16 Dec 2022 0.05 现金
31 Aug 2022 11 Aug 2022 16 Sep 2022 0.05 现金
31 May 2022 13 May 2022 17 Jun 2022 0.05 现金
28 Feb 2022 17 Feb 2022 18 Mar 2022 0.05 现金
30 Nov 2021 11 Nov 2021 17 Dec 2021 0.04 现金
31 Aug 2021 05 Aug 2021 17 Sep 2021 0.04 现金
28 May 2021 12 May 2021 18 Jun 2021 0.04 现金
04 Mar 2021 17 Feb 2021 19 Mar 2021 0.04 现金
30 Nov 2020 11 Nov 2020 18 Dec 2020 0.04 现金
31 Aug 2020 06 Aug 2020 18 Sep 2020 0.04 现金
29 May 2020 12 May 2020 19 Jun 2020 0.04 现金
06 Mar 2020 - 20 Mar 2020 0.04 现金
29 Nov 2019 - 20 Dec 2019 0.04 现金
30 Aug 2019 - 20 Sep 2019 0.04 现金
31 May 2019 - 21 Jun 2019 0.04 现金
04 Mar 2019 - 22 Mar 2019 0.04 现金
30 Nov 2018 - 21 Dec 2018 0.04 现金
31 Aug 2018 - 21 Sep 2018 0.04 现金
01 Jun 2018 - 22 Jun 2018 0.04 现金
05 Mar 2018 - 23 Mar 2018 0.04 现金
01 Dec 2017 - 22 Dec 2017 0.04 现金
31 Aug 2017 - 22 Sep 2017 0.04 现金
01 Jun 2017 - 23 Jun 2017 0.04 现金
06 Mar 2017 21 Feb 2017 24 Mar 2017 0.04 现金
01 Dec 2016 10 Nov 2016 23 Dec 2016 0.04 现金
01 Sep 2016 - 23 Sep 2016 0.04 现金
02 Jun 2016 13 May 2016 24 Jun 2016 0.04 现金
02 Mar 2016 - 24 Mar 2016 0.04 现金
显示更多

每年股息收益率

年份 每年总股息 ($) 频率/年份 收益率 %
2025 0.050 1 0.13
2024 0.200 4 0.34
2023 0.200 4 0.27
2022 0.200 4 0.29
2021 0.160 4 0.19
2020 0.160 4 0.30
2019 0.160 4 0.31
2018 0.160 4 0.54
2017 0.160 4 0.47
2016 0.160 4 0.76
显示更多

支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明：以上内容仅供参考，并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2025 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票